טוען...
A review of clinical treatment considerations of donepezil in severe Alzheimer's disease
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder that affects over 45 million people worldwide. Patients with severe AD require help with daily activities and show severe memory impairment. Currently, donepezil is one of two drugs approved by FDA and Health Canada for the tr...
שמור ב:
| הוצא לאור ב: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6489741/ https://ncbi.nlm.nih.gov/pubmed/30058285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13035 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|